Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FELINE: Ribociclib + Letrozole as Neoadjuvant Therapy in Early Breast Cancer
NCT02712723Phase 2Active, not recruiting
- Sponsor
- Qamar Khan
- Start
- Feb 2016
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ribociclib in breast cancer, sponsored by Qamar Khan. Started Feb 2016; status: active, not recruiting.
02
Drugs
ribociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02712723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02712723.